Scientists have uncovered promising clues that compounds found in Aloe vera could play a role in fighting Alzheimer’s disease ...
A major international study shows that increasing a naturally occurring molecule can help restore memory in animal models of ...
MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced ...
Alzheimer's disease has long been thought to be irreversible, but new research using a mouse model offers hope.
Scientists have uncovered an intriguing link between infection and brain health, finding that a common bacterium in the eye appears to be linked to cognitive decline and Alzheimer’s disease. It's the ...
In this video, James E. Galvin, MD, MPH, professor of neurology and psychiatry and behavioral sciences at the University of Miami Miller School of Medicine, discusses how the treatment landscape for ...
Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: ...
The tablet-based TabCAT tool demonstrates strong convergent validity with traditional tests for early-onset Alzheimer disease (EOAD).
MerryLife Biomedical Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases, today announced positive Phase 1 results for TML-6 ...
Stopping Alzheimer’s may begin with dissolving tiny tau protein clusters before damage takes hold.
Indiana University researchers are advancing the fight against Alzheimer’s disease using brain organoids, cutting-edge ...
Xanamem is an investigational product and is not approved for use outside of a clinical trial by the FDA or by any global regulatory authority. Xanamem ® is a trademark of Actinogen Medical.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results